当前位置: X-MOL 学术ACS Pharmacol. Transl. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Rising Academic Contributions to Drug Development: Evidence of Vigor or Trauma?
ACS Pharmacology & Translational Science Pub Date : 2020-10-28 , DOI: 10.1021/acsptsci.0c00167
Michael S Kinch 1 , Caitlin Horn 1 , Zachary Kraft 1 , Tyler Schwartz 1
Affiliation  

We analyzed therapeutic areas most commonly targeted by academia since 2001, finding a domination of certain oncology and infectious diseases. These findings raise important questions about whether this trend reflects an expanded opportunity arising from academic research or a troubling sign of an industry struggling with the challenges of innovation.

中文翻译:

对药物开发的学术贡献不断增加:活力还是创伤的证据?

我们分析了自 2001 年以来学术界最常针对的治疗领域,发现某些肿瘤学和传染病占主导地位。这些发现提出了一个重要问题,即这种趋势是反映了学术研究带来的机会扩大,还是行业在应对创新挑战的令人不安的迹象。
更新日期:2020-12-12
down
wechat
bug